MedElevator
Войти в исследования Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026
Short- and Long-term Outcomes of Mediastinoscopic Radical Esophagectomy Compared with Open Esophagectomy for Esophageal Cancer: A Consecutive Single-Institution Cohort Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Komatsu Shuhei, Konishi Tomoki, Ogawa Soichiro, Matsumoto Yoshihisa, Fujita Yuji, Matsuo Hisataka, Kuriu Yoshiaki, Ikoma Hisashi, Okamoto Kazuma, Konishi Hirotaka, Fujiwara Hitoshi, Otsuji Eigo, Shiozaki Atsushi
Аннотация
BACKGROUND: Mediastinoscopic esophagectomy has emerged as a non-transthoracic minimally invasive approach, but concerns remain regarding its oncologic adequacy and long-term outcomes. We evaluated short-term morbidity and long-term survival after mediastinoscopic versus open esophagectomy for esophageal cancer.
METHODS: From an institutional esophagectomy database comprising 330 patients, 116 consecutive patients with pathological stage I-III esophageal cancer who underwent curative esophagectomy between 2007 and 2025 in the modern neoadjuvant era were analyzed. Data were collected retrospectively until 2017 and prospectively thereafter. Fifty-six patients underwent open esophagectomy and 60 underwent mediastinoscopic esophagectomy.
RESULTS: Baseline pathological stage and neoadjuvant chemotherapy use were comparable between groups. Despite comparable tumor-related characteristics, patients undergoing mediastinoscopic esophagectomy were significantly older and more frequently classified as ASA physical status ≥ III. Mediastinoscopic esophagectomy was associated with lower blood loss (median 147 vs 500mL, P < 0.001), a shorter postoperative hospital stay (median 14 vs 29 days, P < 0.001), and fewer severe postoperative complications (Clavien-Dindo grade ≥ III; 11.7% vs 41.1%, P < 0.001), without reducing lymph node yield or increasing recurrent laryngeal nerve palsy. On multivariable analysis, mediastinoscopic esophagectomy independently reduced the risk of severe complications (odds ratio 0.11, 95% confidence interval 0.03-0.35, P < 0.001). Overall survival and cancer-specific survival were comparable to those of open esophagectomy. Three- and five-year cancer-specific survival rates were 82.7% and 82.7% after mediastinoscopic esophagectomy and 75.4% and 71.0% after open esophagectomy.
CONCLUSION: Mediastinoscopic esophagectomy provides a substantial reduction in severe postoperative morbidity while maintaining long-term oncologic outcomes comparable to those of open esophagectomy.
METHODS: From an institutional esophagectomy database comprising 330 patients, 116 consecutive patients with pathological stage I-III esophageal cancer who underwent curative esophagectomy between 2007 and 2025 in the modern neoadjuvant era were analyzed. Data were collected retrospectively until 2017 and prospectively thereafter. Fifty-six patients underwent open esophagectomy and 60 underwent mediastinoscopic esophagectomy.
RESULTS: Baseline pathological stage and neoadjuvant chemotherapy use were comparable between groups. Despite comparable tumor-related characteristics, patients undergoing mediastinoscopic esophagectomy were significantly older and more frequently classified as ASA physical status ≥ III. Mediastinoscopic esophagectomy was associated with lower blood loss (median 147 vs 500mL, P < 0.001), a shorter postoperative hospital stay (median 14 vs 29 days, P < 0.001), and fewer severe postoperative complications (Clavien-Dindo grade ≥ III; 11.7% vs 41.1%, P < 0.001), without reducing lymph node yield or increasing recurrent laryngeal nerve palsy. On multivariable analysis, mediastinoscopic esophagectomy independently reduced the risk of severe complications (odds ratio 0.11, 95% confidence interval 0.03-0.35, P < 0.001). Overall survival and cancer-specific survival were comparable to those of open esophagectomy. Three- and five-year cancer-specific survival rates were 82.7% and 82.7% after mediastinoscopic esophagectomy and 75.4% and 71.0% after open esophagectomy.
CONCLUSION: Mediastinoscopic esophagectomy provides a substantial reduction in severe postoperative morbidity while maintaining long-term oncologic outcomes comparable to those of open esophagectomy.